187 related articles for article (PubMed ID: 30681594)
1. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report.
Lin Y; Shi L; Deng YJ; Liu Y; Zhang HW
Medicine (Baltimore); 2019 Jan; 98(4):e14203. PubMed ID: 30681594
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease shock syndrome: case report.
Yang HF; Chen WL; Chang CN; Chen SJ; Fan HC
Paediatr Int Child Health; 2016 Feb; 36(1):76-8. PubMed ID: 25695906
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome in children with Kawasaki disease: diagnostic and therapeutic approaches.
Han SB; Lee SY
World J Pediatr; 2020 Dec; 16(6):566-574. PubMed ID: 32418074
[TBL] [Abstract][Full Text] [Related]
4. Kawasaki disease complicated with shock syndrome, macrophage activation syndrome, and acute abdomen in children: Two case reports.
Yi C; She X; Chen J
Front Pediatr; 2023; 11():1152242. PubMed ID: 37152308
[TBL] [Abstract][Full Text] [Related]
5. [Macrophage activation syndrome and Kawasaki disease: Four new cases].
Dumont B; Jeannoel P; Trapes L; Rolland E; Gay C; Stephan JL
Arch Pediatr; 2017 Jul; 24(7):640-646. PubMed ID: 28583781
[TBL] [Abstract][Full Text] [Related]
6. High-dose anakinra as treatment for macrophage activation syndrome caused by refractory Kawasaki disease in an infant.
Lind-Holst M; Hartling UB; Christensen AE
BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31383678
[TBL] [Abstract][Full Text] [Related]
7. Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review.
Liu J; Yang C; Zhang Z; Li Y
BMC Pulm Med; 2022 Jun; 22(1):220. PubMed ID: 35668424
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study.
Chen PS; Chi H; Huang FY; Peng CC; Chen MR; Chiu NC
J Microbiol Immunol Infect; 2015 Feb; 48(1):43-50. PubMed ID: 23927822
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome in children with Kawasaki disease: an experience from a tertiary care hospital in northwest India.
Pilania RK; Jindal AK; Johnson N; Prithvi A; Vignesh P; Suri D; Rawat A; Gupta A; Singh S
Rheumatology (Oxford); 2021 Jul; 60(7):3413-3419. PubMed ID: 33221920
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features of Kawasaki disease complicated by macrophage activation syndrome: an analysis of 27 cases].
Wen YN; Chen J; Liu F; Ding Y; Yin W
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jun; 25(6):572-578. PubMed ID: 37382125
[TBL] [Abstract][Full Text] [Related]
11. Kawasaki Disease Complicated With Macrophage Activation Syndrome: A Systematic Review.
García-Pavón S; Yamazaki-Nakashimada MA; Báez M; Borjas-Aguilar KL; Murata C
J Pediatr Hematol Oncol; 2017 Aug; 39(6):445-451. PubMed ID: 28562511
[TBL] [Abstract][Full Text] [Related]
12. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
13. A Challenging Diagnosis of Kawasaki Disease Shock Syndrome Complicated by Bilateral Pleural Effusion: A Case Report and Literature Review.
Alghamdi LSA; Alzahrani AYB; Alghamdi FA; ALghamdi SJ
Cureus; 2023 Nov; 15(11):e49671. PubMed ID: 38161959
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in Kawasaki disease: more common than we thought?
Wang W; Gong F; Zhu W; Fu S; Zhang Q
Semin Arthritis Rheum; 2015 Feb; 44(4):405-10. PubMed ID: 25200945
[TBL] [Abstract][Full Text] [Related]
15. Kawasaki Disease and Kawasaki Disease Shock Syndrome Hospitalization Rates in the United States, 2006-2018.
Maddox RA; Person MK; Kennedy JL; Leung J; Abrams JY; Haberling DL; Schonberger LB; Belay ED
Pediatr Infect Dis J; 2021 Apr; 40(4):284-288. PubMed ID: 33264213
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation syndrome in Kawasaki disease.
Mukherjee D; Pal P; Kundu R; Niyogi P
Indian Pediatr; 2014 Feb; 51(2):148-9. PubMed ID: 24632699
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children.
Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M
Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study.
Park WY; Lee SY; Kim GB; Song MK; Kwon HW; Bae EJ; Choi EH; Park JD
BMC Pediatr; 2021 Jan; 21(1):25. PubMed ID: 33413220
[TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease.
Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M
Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features, treatment, and outcomes of macrophage activation syndrome in 80 children: a multi-center study in China.
Zou LX; Zhu Y; Sun L; Ma HH; Yang SR; Zeng HS; Xiao JH; Yu HG; Guo L; Xu YP; Lu MP
World J Pediatr; 2020 Feb; 16(1):89-98. PubMed ID: 31612427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
